510(k) Report

510(k) · Cleared

Cleared

Lin-Zhi International, Inc. (LZI) Methamphetamine Enzyme Immunoassay for Pictus Analyzers

K201442510(k) TraditionalCleared Jul 31, 202060-day reviewClass II21 CFR 862.3610

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diatron Group · LAF Gas Chromatography, Methamphetamine

Cleared on Jul 31, 2020 as substantially equivalent to K113661 (Lin-Zhi International, Inc., 2012) after a 60-day review. Its family tree reaches back 4 generations to 1994.

Decided
Jul 31, 2020
Review
60 days
Class
Class II
Product code
LAF
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K934891 (1994). No later device cites it as a predicate yet.

  1. Root · 4 generations backK934891 Amphetamines Eia Assay ModificationDiagnostic Reagents, Inc. · 1994
  2. 3 generations backK020395 Amphetamines Enzyme Immunoassay, Catalog #0040 (500 Tests Kit)…Lin-Zhi International, Inc. · 2002
  3. 2 generations backK102210 Lzi Amphetamines 500 Homogenous Enzyme Immunoassay; Lzi Amphetamines…Lin-Zhi International, Inc. · 2010
  4. 1 generation backK113661 Lzi Methamphetamine Enzyme Mmunoassay, Lzi Methamphetamine…Lin-Zhi International, Inc. · 2012
  5. This deviceK201442 Lin-Zhi International, Inc. (LZI) Methamphetamine Enzyme Immunoassay…Diatron Group · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K934891Amphetamines Eia Assay ModificationDiagnostic Reagents, Inc.1994—
−3K020395Amphetamines Enzyme Immunoassay, Catalog #0040 (500 Tests Kit), Catalog #0041…Lin-Zhi International, Inc.2002—
−2K102210Lzi Amphetamines 500 Homogenous Enzyme Immunoassay; Lzi Amphetamines 500…Lin-Zhi International, Inc.2010—
−1K113661Lzi Methamphetamine Enzyme Mmunoassay, Lzi Methamphetamine Calibrators, Lzi…Lin-Zhi International, Inc.2012—
0 (this device)K201442Lin-Zhi International, Inc. (LZI) Methamphetamine Enzyme Immunoassay for…Diatron Group2020—
FIG. 1 — Lineage of K201442, 1994–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LAF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LAF device

  1. #1 K203647 SEFRIA Methamphetamine Oral Fluid Enzyme…score 3.8 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K113661Lzi Methamphetamine Enzyme Mmunoassay, Lzi Methamphetamine Calibrators, Lzi…
Summary page 4
…Panel: Toxicology 91 807.92 (a)(3): Identification of the legally marketed predicate devices LZI Methamphetamine Immunoassay reagent cleared under K113661 807.92 (a)(4): Device Description Methamphetamine Lin-Zhi International, Inc. (LZI) Methamphetamine Enzyme Immunoassay for P…
Lin-Zhi International, Inc.2012—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 3 companies; a new generation was cleared every 8.5 years on median.
  • None of the 4 ancestors has a recall.

How does its category compare?

All LAF devices

LAF Gas Chromatography, Methamphetamine: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · LAF

2in 2021

2008: 22011: 42012: 22014: 22015: 32016: 12017: 12020: 12021: 2
2007high 4 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LAF

43in 2015

2011: 345 days median2015: 43 days median
2007high 345 (2011) · low 43 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LAF

No recall names LAF since 2007.

Adverse event reports per year · LAF

No MAUDE report names LAF since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—00
20090—00
20100—00
2011434500
20122—00
20130—00
20142—00
201534300
20161—00
20171—00
20180—00
20190—00
20201—00
20212—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The Lin-Zhi International, Inc. (LZI) Methamphetamine Enzyme Immunoassay for Pictus Analyzers is intended for the qualitative determination of d-methamphetamine in human urine at a cutoff value of 500 ng/mL. The system was calibrated with d-methamphetamine. The assay provides a rapid screening procedure for determining the presence of d-methamphetamine in urine. The assay provides only a preliminary analytical result. A more specific alternative…

Read the full statement (112 words)

The Lin-Zhi International, Inc. (LZI) Methamphetamine Enzyme Immunoassay for Pictus Analyzers is intended for the qualitative determination of d-methamphetamine in human urine at a cutoff value of 500 ng/mL. The system was calibrated with d-methamphetamine. The assay provides a rapid screening procedure for determining the presence of d-methamphetamine in urine.

The assay provides only a preliminary analytical result. A more specific alternative analytical chemistry method must be used in order to obtain a confirmed analytical result. Gas or Liquid Chromatography/Mass Spectrometry (GC/MS or LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary test result is positive.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K201442: Lin-Zhi International, Inc. (LZI) Methamphetamine Enzyme Immunoassay for Pictus Analyzers.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K201442

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026